Nobel Biocare Holding AG (Nobel Biocare Holding AG) EV-to-EBIT : 25.49 (As of Jun. 15, 2024)

Nobel Biocare Holding AG EV-to-EBIT Chart

Nobel Biocare Holding AG Annual Data
	Trend	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Dec13
EV-to-EBIT		Get a 7-Day Free Trial					18.29	14.48	14.81	10.70	20.34

Nobel Biocare Holding AG Semi-Annual Data
	Dec02	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Dec13
EV-to-EBIT	Get a 7-Day Free Trial							18.29	14.48	14.81	10.70	20.34

Competitive Comparison of Nobel Biocare Holding AG's EV-to-EBIT

For the Medical Instruments & Supplies subindustry, Nobel Biocare Holding AG's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nobel Biocare Holding AG's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Nobel Biocare Holding AG's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Nobel Biocare Holding AG's EV-to-EBIT falls into.

Nobel Biocare Holding AG EV-to-EBIT Calculation

Nobel Biocare Holding AG's EV-to-EBIT for today is calculated as:

Nobel Biocare Holding AG's current Enterprise Value is $2,235.1 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Nobel Biocare Holding AG's EBIT for the trailing twelve months (TTM) ended in Dec. 2013 was $87.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nobel Biocare Holding AG  (OTCPK:NBHGF) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Nobel Biocare Holding AG's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2013 is calculated as:

Nobel Biocare Holding AG's Enterprise Value for the quarter that ended in Dec. 2013 was $1,642.2 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Nobel Biocare Holding AG's EBIT for the trailing twelve months (TTM) ended in Dec. 2013 was $87.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nobel Biocare Holding AG EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Nobel Biocare Holding AG's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Nobel Biocare Holding AG (Nobel Biocare Holding AG) Business Description